Navigation Links
Boehringer Ingelheim's investigational volasertib receives FDA Breakthrough Therapy designation
Date:9/17/2013

andclinic.org/disorders/acute_myeloid_leukemia/hic_adult_acute_myeloid_leukemia.aspx">http://my.clevelandclinic.org/disorders/acute_myeloid_leukemia/hic_adult_acute_myeloid_leukemia.aspx. [Last Accessed: November 1, 2012]
3 Deschler B et al. Acute Myeloid Leukemia: Epidemiology and Etiology. Cancer. 2006. 2009-2107.
4 The Leukemia and Lymphoma Society. Facts. Spring 2013. Available at: http://www.lls.org/content/nationalcontent/resourcecenter/freeeducationmaterials/generalcancer/pdf/facts.pdf. Last Accessed: June 25, 2013
5National Marrow Donor Program. Acute Myelogenous Leukemia (AML). Available at: http://marrow.org/Patient/Disease_and_Treatment/About_Your_Disease/AML/Acu te_Myelogenous_Leukemia_(AML).aspx#MakingTreatmentDecisions. [Last Accessed: November 1, 2012]
6 Texas Oncology. Acute Myeloid Leukemia Induction, Overview. Available at: http://www.texasoncology.com/types-of-cancer/leukemia/acute-myeloid-leukemia/acute-myeloid-leukemia-induction/ [Last Accessed: November 21, 2012]
7 The Leukemia and Lymphoma Society. Acute Myeloid Leukemia: Treatment Outcomes. Available at: http://www.lls.org/#/diseaseinformation/leukemia/acutemyeloidleukemia/treatment/outcomes/. Last Accessed: November 1, 2012
8 ClinicalTrials.gov. Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2). Available at: http://clinicaltr
'/>"/>

SOURCE Boehringer Ingelheim
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
2. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
4. Boehringer Ingelheim Renews and Expands License to NextBio Research Platform
5. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
6. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
7. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
8. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
9. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
10. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
11. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... 27 Puroast(R) Low Acid Coffee,has conducted both ... its great tasting, gourmet coffee provides symptom relief ... brew. Puroast(R) achieves,this without extractions, substitutes or additives; ... full-bodied taste., Prior chemistry research at University ...
... Emerging Data Shows Encouraging Response in CF Patients ... BETHESDA, Md., March 27 The Cystic Fibrosis ... that targets a,basic defect in CF, showed promising results ... carry the G551D mutation of CF. The drug is,being ...
Cached Medicine Technology:Low Acid Coffee Backed By Scientific Research 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3
(Date:8/29/2015)... ... August 29, 2015 , ... Targeted therapies, made possible ... lives of patients, according to a newly published report. Surviving Mesothelioma has more ... article. , The authors of the new paper focus on several types ...
(Date:8/29/2015)... ... 2015 , ... Brands like Toppik , Eau Thermale Avene and Bliss ... a threshold of $49.00 was required to qualify for free standard shipping,” said Jennifer ... shipping for customers regardless of the item’s selling price.” , With competitive pricing in ...
(Date:8/29/2015)... ... ... ProDrop Particles includes over 40 particle backdrops designed for use in ... users can shrink and stretch in the Final Cut Pro X timeline. Choose from ... scale, speed, range, and flare attributes with intuitive controls found in the top-right inspector ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, ... ... consistently successful results and include treating the localized area with stretching, soft tissue ... and a neutral pelvic position have shown through research to improve treatment ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... freely market and sell Arterosil and Arterosil HP, and that all claims and ... sued Vascular Health Sciences, LLC (VHS) in the United States District Court for ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... this New Digest: , , Summary of ... the Journal of Clinical Oncology ,showing no ... cancer whose ovaries were left intact during cancer ... removed., Quote for attribution from Beth Karlan, MD, ...
... and Spanish . , A research work carried ... University of Granada has carried out an analysis of the ... most of them belong to the group of lactic bacteria, which ... for health. The doctoral thesis by Antonio M. Martn Platero ...
... High-Quality Care to Homeless Animals and the Public, Regardless ... Spay/Neuter 12,000 Cats and Dogs in 2009 -- Double ... The San Francisco SPCA today announced the opening of ... home of its nonprofit Veterinary Hospital, Spay/Neuter Clinic and ...
... Collaborate and Achieve ComplianceHOPKINTON, Mass., Jan. 28 ... world leader in information infrastructure solutions, today announced ... (DCM) to centrally store, review, approve and manage ... procedures (SOPs). As a result, RadPharm has ...
... Sunday throughout February, Sharing Miracles , a 30-minute ... inspirational stories of real patients, will feature television actress ... the hit sitcom Family Ties . Sharing ... across the United States. Though perhaps best known for ...
... Swiss Re,s Employer Stop Loss insurance coverage is ... in self-funding their employee health plans in the United ... liability and benefit from self-funding their employee health plans. ... in all 50 states and the District of Columbia ...
Cached Medicine News:Health News:Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause 2Health News:Most bacteria from craft goat's cheese come from lactic acid and could be beneficial for health 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 2Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 3Health News:San Francisco SPCA Dramatically Expands Charitable Veterinary Care With Opening of Leanne B. Roberts Animal Care Center 4Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 2Health News:RadPharm Finds Cure to Efficiently Manage Regulated Documents with EMC 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 2Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 3Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 4Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 5Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 6Health News:'Sharing Miracles' Television Program to Feature Emmy Award-Nominated Actress Meredith Baxter 7Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 2Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 3
... This comfortable pre-fabricated orthosis is designed ... distal third humeral diaphyseal fractures. The ... circumferential soft tissue compression for optimal ... range-of- motion of both shoulder and ...
... comfortable pre-fabricated orthosis is designed for ... third humeral diaphyseal fractures. The lightweight ... soft tissue compression for optimal control ... range-of-motion of both the shoulder and ...
Controls humeral segments through soft tissue compression while allowing for full range of elbow motion...
... Splint is indicated for the treatment of ... economical and easy to apply. The splint ... dorsiflexion, limiting nightly contractures and tightening of ... feature permits flexibility in the treatment of ...
Medicine Products: